Clinical trial
Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel
NCT00210171 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel
- Lead sponsor
- Institut Bergonié
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- May 31, 2004
- Completion date
- May 31, 2004
- Enrollment
- 0 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.